Feature Summary

Curcumin’s role in the prevention of atherosclerotic plaque formation, platelet aggregation, and LDL oxidation indicates multi-fold cardiovascular benefits, and its ability to inhibit angiogenesis and induce apoptosis in cancer cells suggests both preventative and therapeutic benefits.^1–4 Prospective clinical trial data has also shown the effectiveness of Theracurmin for knee osteoarthritis symptom relief, and a decreased need for rescue medication. ⁵

The limiting factor in curcumin’s efficacy has been its poor systemic bioavailability, as it is poorly absorbed in the gastrointestinal tract and rapidly metabolized.⁶ Advanced manufacturing techniques used to make Theracurmin have reduced its particle size over 100-fold, and the combined use of natural emulsifiers to form a colloidal suspension has tremendously increased curcumin’s bioavailability. This significantly increases blood levels of curcumin many times that of other preparations, including so-called enhanced forms of curcumin. Theracurmin increases curcumin levels in a linear and dose-dependent manner, bypassing previous limits of curcumin supplementation to achieve unparalleled blood levels of curcumin.^7,8 Detailed absorption studies have proven that Theracurmin is the best-absorbed form of curcumin on the market.